Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

28 Apr 2005 07:00

Torex Retail PLC28 April 2005 Torex Retail Plc AGM Statement Torex Retail Plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, will today hold its inaugural Annual General Meeting. RobLoosemore, Chairman, will comment on current trading as follows: "Torex Retail performed strongly in 2004 and the momentum developed during lastyear has been carried forward into 2005. We are pleased to report that tradingto date is in line with our expectations and, with buoyant market conditions anda high level of revenue visibility, the Board remain confident of both our fullyear forecasts and the future growth prospects for the Group. In addition, we are delighted with the progress made by the Alphameric RetailDivision (ARD), which was acquired in November 2004, and which continues totrade in line with our expectations. This reflects new business wins (AnnTaylor and Littlewoods) for our Smartdecision merchandise planning product,coupled with decisive action taken to reduce the cost base. The division is nowfully integrated into the Torex Retail business." Other highlights include: • First installations of Lucas into the UK: Following the successful launch in the UK of Lucas, our market leading Java EPOS solution, installations have already been completed with Esprit, Deichmann shoe stores and a major regional department store. Further announcements are expected shortly. • Cross selling of Lucas is ahead of schedule. The very strong demand for Lucas from the former ARD customer base has resulted in a number of early contract wins, including JD Sports with installations into their 68 UK stores planned for the next quarter. In addition, Lucas has already been installed in Reiss' flagship New York store and Nora O'Connell stores in Ireland. Chris Moore, Chief Executive, comments: "I am delighted with the start we have made to the year. Most encouraging hasbeen the new contract wins for Lucas, in particular, the deal with JD Sports inthe face of stiff competition. This win, together with the UK Lucas sales, willprovide valuable reference sites from which to leverage Lucas further into theUK market. The outlook for the full year remains very positive." It is expected that the Group's interim results for the six months ending 30June, 2005 will be announced in mid September 2005. Enquiries: Torex Retail 0870 050 9900 Rob Loosemoore, Chairman / Richard Thompson, FD Citigate Dewe Rogerson 020 7638 9571 Ginny Pulbrook / Sebastian Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20207:00 amRNSUpdate in relation to working capital position
20th Mar 20207:00 amRNSDirectorate Change
6th Feb 20207:15 amEQSHardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
4th Feb 202011:47 amRNSResolution of Cyber Security Incident
28th Jan 202010:02 amRNSNotice of cyber security incident
22nd Jan 20207:00 amRNSTrading Update
14th Jan 20204:40 pmRNSSecond Price Monitoring Extn
14th Jan 20204:35 pmRNSPrice Monitoring Extension
21st Nov 20194:35 pmRNSPrice Monitoring Extension
18th Nov 20194:03 pmRNSDirectorate Change
14th Nov 20194:00 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSUpdated loan facility agreement with MidCap
13th Nov 20193:35 pmRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
11th Nov 20192:05 pmRNSSecond Price Monitoring Extn
11th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSUpdate in relation to loan facility
17th Oct 20194:27 pmRNSHolding(s) in Company
17th Oct 20197:00 amRNSTrading Update
15th Oct 20193:27 pmRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDermaPure Product Line Extension Launched
10th Sep 20197:00 amRNSUnaudited Interim Results
28th Aug 20197:00 amRNSAppointment of CFO
15th Aug 20197:00 amRNSAdditional manufacturing capacity secured
1st Aug 20197:00 amRNSDirectorate Change
8th Jul 20195:03 pmRNSHolding(s) in Company
20th Jun 20192:23 pmEQSHardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021
7th Jun 20192:55 pmRNSIssue of Equity and Total Voting Rights
4th Jun 20197:00 amRNSNotice of AGM
4th Jun 20197:00 amRNSSecures Credit Facilities of up to $20m
4th Jun 20197:00 amRNSAnnual Results for the year ended 31 December 2018
21st May 20197:00 amRNSCEO to return to full time duties
10th Apr 20197:20 amEQSHardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
4th Apr 20197:26 amRNSExpands US GPO coverage for DermaPure
18th Feb 20197:00 amRNSChange of Adviser
6th Feb 201911:05 amRNSSecond Price Monitoring Extn
6th Feb 201911:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Update
17th Dec 201811:56 amEQSHardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
6th Dec 20187:00 amRNSInterim Management Change
13th Nov 20187:00 amRNSPan European distribution agreement with Arthrex
29th Oct 20187:00 amRNSGareth Jones commences position as CFO
14th Sep 20187:16 amEQSHardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
3rd Sep 20187:00 amRNSUnaudited Interim Results
2nd Aug 201810:10 amEQSHardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
2nd Aug 20187:00 amRNSNotice of Interim Results
4th Jul 20187:00 amRNSAppointment of CFO
25th Jun 20187:00 amRNSHTA License granted and UK distribution Agreement
21st Jun 20187:10 amRNSTRX BioSurgery wins GPO Supplier Horizon Award
18th Jun 20187:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.